A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer

Biophysics Reviews
Rama Rao MallaPrasuja Rokkam

Abstract

Triple-negative breast cancer (TNBC) is the most aggressive and prevalent subtype of breast cancer in women worldwide. Currently, chemotherapy remains the main modality for the treatment at an early stage, as there is no approved targeted therapy for early TNBC. In this review, we investigate the use of microRNAs (miRNAs), which play a key role in the post-transcriptional regulation of genes involved in the key biological processes, namely proliferation, differentiation, angiogenesis, migration, apoptosis, and carcinogenesis. Here, we emphasize the importance of the recent advances related to miRNAs, involving diagnosis, prognosis, and treatment of TNBC. We focus on the development, optimization, and stabilization of miRNA-based drugs; improvement of miRNA delivery; and control of the off-target effects of miRNA therapeutics. We speculate as to which features may present themselves as promising approaches in the treatment of TNBC.

References

Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jun 10, 2005·Nature·Lin HeScott M Hammond
Jul 19, 2005·Cancer Research·Jennifer A ChanKenneth S Kosik
May 20, 2006·Science·Nathaniel L RosiChad A Mirkin
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·John A FoekensJohn W M Martens
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Feb 25, 2010·Cell·Srinivas R Viswanathan, George Q Daley
Mar 2, 2010·Cell Cycle·Fadila GuessousRoger Abounader
Apr 8, 2010·The Journal of Biological Chemistry·William KongJin Q Cheng
May 28, 2010·Breast Cancer Research and Treatment·Hongling LiRobert Chunhua Zhao
Oct 14, 2010·Molecular Cancer Therapeutics·Kristi E Allen, Glen J Weiss
Oct 30, 2010·Seminars in Cancer Biology·Ulf Klein, Riccardo Dalla-Favera
Mar 29, 2012·The Cancer Journal·Diwakar DavarJohn M Kirkwood
May 25, 2012·The Journal of Clinical Investigation·Jason E Fish, Myron I Cybulsky
May 25, 2012·Clinical and Experimental Medicine·Laisheng LiXiaoming Xie
Nov 28, 2012·Pharmaceutical Research·Zhongxing LiangHyunsuk Shim
Jan 11, 2013·Journal of Oncology·Michel Herranz, Alvaro Ruibal
Jan 12, 2013·Genes & Development·Nila Roy ChoudhuryGracjan Michlewski
Nov 7, 2013·PloS One·Katarina CukBarbara Burwinkel
Nov 13, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Enders K O NgAva Kwong
Nov 30, 2013·Breast Cancer Research : BCR·Suzanne A EcclesAlastair M Thompson
Mar 13, 2014·Cancer Biology & Therapy·Ren-Chin WuIe-Ming Shih
Jan 1, 2012·MicroRNA·Benjamin I Laufer, Shiva M Singh
Nov 5, 2014·Cancer Research·Eun Young ParkJong Hoon Park
Dec 31, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kristine Kleivi SahlbergLibero Santarpia
Jan 11, 2016·Cancer Science·Akihiko ShimomuraTakahiro Ochiya
Jul 9, 2016·Journal of Cancer·Xiaofeng DaiZhonghu Bai
Aug 12, 2016·Cell Death & Disease·Ye SuAnthony M Jevnikar
May 6, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Seema KumariRamaRao Malla
Aug 7, 2017·Experimental and Therapeutic Medicine·Quanqing ZouDong Huang

❮ Previous
Next ❯

Citations

Jul 11, 2020·Dose-response : a Publication of International Hormesis Society·Mengwei XieShifeng Li
Jun 1, 2021·Frontiers in Cellular and Infection Microbiology·Geraldo Magela de Faria JuniorLuiz Carlos de Mattos
Jul 1, 2020·Current Pharmaceutical Biotechnology·Acharya BalkrishnaVedpriya Arya

❮ Previous
Next ❯

Methods Mentioned

BETA
pull-out

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
WenCheng ZhangGuangshun Wang
Cancer Metastasis Reviews
Liqin Du, Alexander Pertsemlidis
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Su Q LiXiu F Cao
Respiratory Medicine
Jennifer F Barger, S Patrick Nana-Sinkam
Zhonghua wai ke za zhi [Chinese journal of surgery]
Song-jie ShenShao-mei Han
© 2022 Meta ULC. All rights reserved